THE SECURITIES EVIDENCED BY THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE
OFFERED, SOLD, DISTRIBUTED, ASSIGNED, PLEDGED OR OTHERWISE TRANSFERRED
UNLESS (A) THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND
APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION INVOLVING
SAID SECURITIES OR (B) THE COMPANY RECEIVES AN OPINION OF LEGAL COUNSEL FOR
THE HOLDER OF THESE SECURITIES (IN FORM AND SUBSTANCE SATISFACTORY TO THE
COMPANY) STATING THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION OR (C)
THE COMPANY OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT FROM
HOLLIS-EDEN PHARMACEUTICALS, INC.
SERIES A WARRANT AGREEMENT
Reissued May 5, 2000
HOLLIS-EDEN PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), hereby grants this
20th day of May 1997, to Richard B. Hollis ("Holder"), a warrant to purchase up to 393,250 shares of Common
stock (the "Common Stock") of the Company at a per share exercise price of $11.02 (the "Warrant Price").
1. Exercisability; Term. This Warrant becomes exercisable on the date that shares underlying the Warrant are
registered under the Securities Act of 1933, as amended (the "Securities Act") and shall expire at 5:00 p.m. PST
on January 7, 2006. The Company hereby undertakes to use its best efforts to file for such registration within one
year after it becomes a public company (whether through a public offering, a business combination with a public
company or otherwise).
2. No Stockholder Rights. This Warrant shall not entitle Holder to any of the rights of a stockholder of the
3. Reservation of Stock. The Company covenants that during the period this Warrant is exercisable, the
Company will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide
for the issuance of the shares upon the exercise of this Warrant. The Company agrees that its issuance of this